Background

Dr. Joan Lau, Ph.D., MBA is founder and managing partner of Militia Hill Ventures. Dr. Lau has been Chief Operating Officer at Immunome, Inc since February 2014. Dr. Lau serves as Chief Executive Officer and President of Ansaris, Inc. Dr. Lau served as Chief Executive Officer and President at Azelon Pharmaceuticals, Inc. Dr. Lau held roles of increasing responsibility in drug discovery and development and business development at Merck & Co., Inc. Dr. Lau served as Chief ... Executive Officer, Chief Operating Officer and President of Locus Pharmaceuticals, Inc. Dr. Lau worked in the pharmaceuticals and device industry for over 10 years. Prior to Ansaris, Dr. Lau served at Merck & Co. where she served roles of increasing responsibility in R&D Project Management, Portfolio Management, and Business Development. During this period, she played significant roles in leading preclinical and early clinical programs and managing the neuroscience drug development portfolio. She managed global business development activities for the Merck Vaccines and Infectious Diseases division. Dr. Lau is also associate course director for the Vagelos Program in Life Sciences Management at the University of Pennsylvani. Dr. Lau served as executive-in-residence at BioAdvance, a funder of life sciences companies in southeastern Pennsylvania. She was responsible to scientific integration in the Office of the President, Merck Research Laboratories. Dr. Lau worked in medical device development at Zimmer, Inc. She serves as a Director of Ansaris, Inc. Dr. Lau has MBA from the Wharton School of Business. She also has a PhD in Medical Neuroscience from the University of Cincinnati College of Medicine. and a BS degree in Bioengineering from the University of Pennsylvania.

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.